Publication Title
Oncotarget
Document Type
Article
Publication Date
7-20-2018
Keywords
cancer; chemotherapy; digestive enzymes; microbiome; probiotic
Abstract
There are numerous downstream consequences of marketed drugs like antineoplastic agents on the gut microbiome, an effect that is suggested to contribute to adverse event profiles and may also influence drug responses. In cancer, progress is needed toward modulation of the host microbiome to prevent off-target side effects of drugs such as gastrointestinal mucositis that result from gut dysbiosis. The objective of this study was evaluation of the bioactivity of a supplement consisting of capsules with a blend of 9 probiotic organisms of the genera
Clinical Institute
Cancer
Specialty/Research Institute
Oncology
